Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) promotes challenging immune and inflammatory phenomena. Though various therapeutic possibilities have been tested against coronavirus disease 2019 (COVID-19), the most adequate treatment has not yet been established. Propolis i...

Descripción completa

Detalles Bibliográficos
Autores principales: Silveira, Marcelo Augusto Duarte, De Jong, David, Berretta, Andresa Aparecida, Galvão, Erica Batista dos Santos, Ribeiro, Juliana Caldas, Cerqueira-Silva, Thiago, Amorim, Thais Chaves, Conceição, Luis Filipe Miranda Rebelo da, Gomes, Marcel Miranda Dantas, Teixeira, Maurício Brito, Souza, Sergio Pinto de, Santos, Marcele Helena Celestino Alves dos, San Martin, Raissa Lanna Araújo, Silva, Márcio de Oliveira, Lírio, Monique, Moreno, Lis, Sampaio, Julio Cezar Miranda, Mendonça, Renata, Ultchak, Silviana Salles, Amorim, Fabio Santos, Ramos, João Gabriel Rosa, Batista, Paulo Benigno Pena, Guarda, Suzete Nascimento Farias da, Mendes, Ana Verena Almeida, Passos, Rogerio da Hora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980186/
https://www.ncbi.nlm.nih.gov/pubmed/34311528
http://dx.doi.org/10.1016/j.biopha.2021.111526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980186/
https://www.ncbi.nlm.nih.gov/pubmed/34311528
http://dx.doi.org/10.1016/j.biopha.2021.111526

Ejemplares similares